135 related articles for article (PubMed ID: 2932669)
21. [Activation of the alternative complement pathway in patients with epidemic hemorrhagic fever].
Gu XS
Zhonghua Nei Ke Za Zhi; 1983 Dec; 22(12):722-5. PubMed ID: 6144469
[No Abstract] [Full Text] [Related]
22. [Complement system in the middle ear effusion--low C1 activity and the activation of complement components through the alternative pathway].
Hanajima T; Takasaka T
Nihon Jibiinkoka Gakkai Kaiho; 1987 Feb; 90(2):211-20. PubMed ID: 3598765
[No Abstract] [Full Text] [Related]
23. Complement alterations in inflammatory bowel disease.
Lake AM; Stitzel AE; Urmson JR; Walker WA; Spitzer RE
Gastroenterology; 1979 Jun; 76(6):1374-9. PubMed ID: 437435
[TBL] [Abstract][Full Text] [Related]
24. Serum complement components in Henoch-Schönlein purpura.
Garcia-Fuentes M; Martin A; Chantler C; Williams DG
Arch Dis Child; 1978 May; 53(5):417-9. PubMed ID: 666358
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
Farries TC; Lachmann PJ; Harrison RA
Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
[TBL] [Abstract][Full Text] [Related]
26. Molecular biology and chemistry of the alternative pathway of complement.
Müller-Eberhard HJ; Schreiber RD
Adv Immunol; 1980; 29():1-53. PubMed ID: 6158260
[No Abstract] [Full Text] [Related]
27. Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
Schreiber RD; Pangburn MK; Lesavre PH; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3948-52. PubMed ID: 279011
[TBL] [Abstract][Full Text] [Related]
28. Complement C3 cleavage and cytokines interleukin-1beta and tumor necrosis factor-alpha in otitis media with effusion.
Närkiö-Mäkelä M; Teppo AM; Meri S
Laryngoscope; 2000 Oct; 110(10 Pt 1):1745-9. PubMed ID: 11037838
[TBL] [Abstract][Full Text] [Related]
29. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
30. Complement activation by Coccidioides immitis: in vitro and clinical studies.
Galgiani JN; Yam P; Petz LD; Williams PL; Stevens DA
Infect Immun; 1980 Jun; 28(3):944-9. PubMed ID: 6901703
[TBL] [Abstract][Full Text] [Related]
31. Solubilization of immune precipitates by six isolated alternative pathway proteins.
Fujita T; Takata Y; Tamura N
J Exp Med; 1981 Dec; 154(6):1743-51. PubMed ID: 6459396
[TBL] [Abstract][Full Text] [Related]
32. Complement in chronic secretory otitis media. C3 breakdown and C3 splitting activity.
Meri S; Lehtinen T; Palva T
Arch Otolaryngol; 1984 Dec; 110(12):774-8. PubMed ID: 6334511
[TBL] [Abstract][Full Text] [Related]
33. The alternative pathway of complement.
Pangburn MK; Müller-Eberhard HJ
Springer Semin Immunopathol; 1984; 7(2-3):163-92. PubMed ID: 6238433
[No Abstract] [Full Text] [Related]
34. The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.
DiScipio RG
Biochem J; 1981 Dec; 199(3):485-96. PubMed ID: 6462133
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.
Aguado MT; Perrin LH; Ramirez R; Miescher PA; Lambert PH
Clin Exp Immunol; 1980 Dec; 42(3):495-505. PubMed ID: 6163579
[TBL] [Abstract][Full Text] [Related]
36. Plasma levels of proteins of the alternative complement pathway in inbred mice that differ in resistance to Trypanosoma congolense infections.
Otesile EB; Lee M; Tabel H
J Parasitol; 1991 Dec; 77(6):958-64. PubMed ID: 1838113
[TBL] [Abstract][Full Text] [Related]
37. Quantitation of components of the alternative pathway of complement (APC) by enzyme-linked immunosorbent assays.
Oppermann M; Baumgarten H; Brandt E; Gottsleben W; Kurts C; Götze O
J Immunol Methods; 1990 Oct; 133(2):181-90. PubMed ID: 2146321
[TBL] [Abstract][Full Text] [Related]
38. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
Fishelson Z; Müller-Eberhard HJ
J Immunol; 1984 Mar; 132(3):1425-9. PubMed ID: 6229580
[TBL] [Abstract][Full Text] [Related]
39. The role of C1s, C1r and properdin in the initiation of the C3b-dependent feedback mechanism of the complement system.
Johnson U
Acta Pathol Microbiol Scand C; 1978 Apr; 86(2):73-8. PubMed ID: 696332
[TBL] [Abstract][Full Text] [Related]
40. Regulation of C5 convertase activity by properdin, factors B and H.
Weiler JM
Immunol Res; 1989; 8(4):305-15. PubMed ID: 2531781
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
